Management of Missed Ceftriaxone (Ceftriaxone) Doses in Serious Infections

Impact of Missed Doses on Central Nervous System (CNS) Infections

Missing a scheduled ceftriaxone dose in CNS infections (e.g., meningitis) is especially concerning because it can lead to sub‑therapeutic cerebrospinal fluid (CSF) concentrations, jeopardizing bacterial eradication. 1, 2, 3
In meningococcal or pneumococcal meningitis treated with ceftriaxone 2 g every 12 hours, a missed dose may produce CSF drug levels below the minimum inhibitory concentration (MIC) needed for effective therapy. 1, 2
When a dose is missed in critically ill patients with meningitis or sepsis, consultation with infectious‑disease specialists is recommended to evaluate the need for therapeutic drug monitoring or regimen adjustment. 1

The UK guidelines advise a 5‑day course for meningococcal meningitis and a 10‑ to 14‑day course for pneumococcal meningitis; maintaining consistent dosing throughout these periods is essential to achieve optimal outcomes. 1, 2
For severe infections requiring high CSF penetration (e.g., meningitis), a twice‑daily ceftriaxone regimen (2 g every 12 h) is recommended over once‑daily dosing to ensure adequate CSF drug levels. 1, 2

In uncomplicated pyelonephritis, ceftriaxone is often administered as a single 1 g IV dose before switching to oral therapy; a brief delay in this single dose is generally not clinically significant. 4

Do not extend the overall treatment duration solely because a dose was missed; adhere to the evidence‑based course lengths (e.g., 5 days for meningococcal, 10‑14 days for pneumococcal meningitis). 1, 2
Reassess the patient’s clinical response if multiple doses are missed or if the infection is severe, to determine whether additional interventions (e.g., therapeutic drug monitoring) are warranted. 1, 2

For patients receiving outpatient IV ceftriaxone, reinforce adherence strategies (such as scheduled nursing visits or reminder systems) to minimize the risk of missed doses. 5